Cargando…
Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage
BACKGROUND: We sought to assess the risk of acute kidney injury (AKI) and mortality associated with intensive systolic blood pressure reduction in acute intracerebral hemorrhage. METHODS AND RESULTS: Patients with acute intracerebral hemorrhage had spontaneous cause and symptom onset within 24 hours...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015439/ https://www.ncbi.nlm.nih.gov/pubmed/29654207 http://dx.doi.org/10.1161/JAHA.117.008439 |
_version_ | 1783334413468172288 |
---|---|
author | Burgess, L. Goodwin Goyal, Nitin Jones, G. Morgan Khorchid, Yasser Kerro, Ali Chapple, Kristina Tsivgoulis, Georgios Alexandrov, Andrei V. Chang, Jason J. |
author_facet | Burgess, L. Goodwin Goyal, Nitin Jones, G. Morgan Khorchid, Yasser Kerro, Ali Chapple, Kristina Tsivgoulis, Georgios Alexandrov, Andrei V. Chang, Jason J. |
author_sort | Burgess, L. Goodwin |
collection | PubMed |
description | BACKGROUND: We sought to assess the risk of acute kidney injury (AKI) and mortality associated with intensive systolic blood pressure reduction in acute intracerebral hemorrhage. METHODS AND RESULTS: Patients with acute intracerebral hemorrhage had spontaneous cause and symptom onset within 24 hours. We excluded patients with structural causes, coagulopathy, thrombocytopenia, and preexisting end‐stage renal disease. We defined AKI using the Acute Kidney Injury Network criteria. Chronic kidney disease status was included in risk stratification and was defined by Kidney Disease Outcomes Quality Initiative staging. Maximum systolic blood pressure reduction was defined over a 12‐hour period and dichotomized using receiver operating characteristic curve analysis. Descriptive statistics were done using independent sample t tests, χ(2) tests, and Mann‐Whitney U tests, whereas multivariable logistic regression analysis was used to evaluate for predictors for AKI and mortality. A total of 448 patients with intracerebral hemorrhage met inclusion criteria. Maximum systolic blood pressure reduction was dichotomized to 90 mm Hg and found to increase the risk of AKI in patients with normal renal function (odds ratio, 2.1; 95% confidence interval, 1.19–3.62; P=0.010) and chronic kidney disease (odds ratio, 3.91; 95% confidence interval, 1.26–12.15; P=0.019). The risk of AKI was not significantly different in normal renal function versus chronic kidney disease groups when adjusted for demographics, presentation characteristics, and medications associated with AKI. AKI positively predicted mortality for patients with normal renal function (odds ratio, 2.41; 95% confidence interval, 1.11–5.22; P=0.026) but not for patients with chronic kidney disease (odds ratio, 3.13; 95% confidence interval, 0.65–15.01; P=0.154). CONCLUSIONS: These results indicate that intensive systolic blood pressure reduction with a threshold >90 mm Hg in patients with acute intracerebral hemorrhage may be an independent predictor for AKI. |
format | Online Article Text |
id | pubmed-6015439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60154392018-07-05 Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage Burgess, L. Goodwin Goyal, Nitin Jones, G. Morgan Khorchid, Yasser Kerro, Ali Chapple, Kristina Tsivgoulis, Georgios Alexandrov, Andrei V. Chang, Jason J. J Am Heart Assoc Original Research BACKGROUND: We sought to assess the risk of acute kidney injury (AKI) and mortality associated with intensive systolic blood pressure reduction in acute intracerebral hemorrhage. METHODS AND RESULTS: Patients with acute intracerebral hemorrhage had spontaneous cause and symptom onset within 24 hours. We excluded patients with structural causes, coagulopathy, thrombocytopenia, and preexisting end‐stage renal disease. We defined AKI using the Acute Kidney Injury Network criteria. Chronic kidney disease status was included in risk stratification and was defined by Kidney Disease Outcomes Quality Initiative staging. Maximum systolic blood pressure reduction was defined over a 12‐hour period and dichotomized using receiver operating characteristic curve analysis. Descriptive statistics were done using independent sample t tests, χ(2) tests, and Mann‐Whitney U tests, whereas multivariable logistic regression analysis was used to evaluate for predictors for AKI and mortality. A total of 448 patients with intracerebral hemorrhage met inclusion criteria. Maximum systolic blood pressure reduction was dichotomized to 90 mm Hg and found to increase the risk of AKI in patients with normal renal function (odds ratio, 2.1; 95% confidence interval, 1.19–3.62; P=0.010) and chronic kidney disease (odds ratio, 3.91; 95% confidence interval, 1.26–12.15; P=0.019). The risk of AKI was not significantly different in normal renal function versus chronic kidney disease groups when adjusted for demographics, presentation characteristics, and medications associated with AKI. AKI positively predicted mortality for patients with normal renal function (odds ratio, 2.41; 95% confidence interval, 1.11–5.22; P=0.026) but not for patients with chronic kidney disease (odds ratio, 3.13; 95% confidence interval, 0.65–15.01; P=0.154). CONCLUSIONS: These results indicate that intensive systolic blood pressure reduction with a threshold >90 mm Hg in patients with acute intracerebral hemorrhage may be an independent predictor for AKI. John Wiley and Sons Inc. 2018-04-13 /pmc/articles/PMC6015439/ /pubmed/29654207 http://dx.doi.org/10.1161/JAHA.117.008439 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Burgess, L. Goodwin Goyal, Nitin Jones, G. Morgan Khorchid, Yasser Kerro, Ali Chapple, Kristina Tsivgoulis, Georgios Alexandrov, Andrei V. Chang, Jason J. Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title | Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title_full | Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title_fullStr | Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title_full_unstemmed | Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title_short | Evaluation of Acute Kidney Injury and Mortality After Intensive Blood Pressure Control in Patients With Intracerebral Hemorrhage |
title_sort | evaluation of acute kidney injury and mortality after intensive blood pressure control in patients with intracerebral hemorrhage |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015439/ https://www.ncbi.nlm.nih.gov/pubmed/29654207 http://dx.doi.org/10.1161/JAHA.117.008439 |
work_keys_str_mv | AT burgesslgoodwin evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT goyalnitin evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT jonesgmorgan evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT khorchidyasser evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT kerroali evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT chapplekristina evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT tsivgoulisgeorgios evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT alexandrovandreiv evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage AT changjasonj evaluationofacutekidneyinjuryandmortalityafterintensivebloodpressurecontrolinpatientswithintracerebralhemorrhage |